DAJY(SZ:002030)2022-12-08 01:56Group 1: Company Overview - The company is called Da An Gene Co., Ltd., with the stock code 002030 [1] - The investor relations activity took place on April 30, 2015, at the company's headquarters in Guangzhou [2] Group 2: Business Focus and Strategy - The current focus of the company is on industrial layout rather than the development of individual segments [2][3] - Each segment of the company's industrial chain is managed by specialized companies to ensure balanced progress [3] Group 3: Market Insights - The market share of the company's second-generation gene sequencing products is currently not available, with data expected by the end of the year [3] - The application of second-generation gene sequencing technology in oncology is still immature, making it difficult to assess its market size [3] Group 4: Future Developments - Da An Gene is closely monitoring advancements in second-generation gene sequencing technology, particularly in oncology, as it is one of the potential application areas [3] - The company is not currently involved in the pharmaceutical sector, focusing primarily on diagnostics [4] Group 5: Corporate Actions - There are no current plans for additional share issuance [4]